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ods and strategies based on CT technology have been explored for dose reduction [11] [12] [13] . When CT is used only for attenuation correction of the PET data, the range of exposure settings that can be used is extremely wide; however there are limitations if the CT data are also used for anatomic localization [14] [15] [16] . Careful consideration of the acquisition parameters is required to achieve low patient dose with acceptable image quality.
The goals of this investigation were optimization of clinical CT acquisition protocols for whole-body PET/CT, reducing radiation dose without a significant degradation of image quality, evaluating mean patient dose from the examination, and assessing the effect on image quality.
Materials and Methods
All data were acquired on a PET/CT scanner (Discovery STE 16, GE Healthcare). Patients were injected with 407-444 MBq (11-12 mCi) of 18 F-FDG and scanned from the head to the mid thighs. The whole-body PET component was performed with a 3-minute acquisition per bed position with the scanner operating in the 3D mode. Normally, scans of 5-7 bed positions were obtained. Estimation of PET radiation dose was based on Publication 80 of the International Commission on Radiological Protection [17] , which suggests 0.019 mSv/MBq of administered activity for an adult patient. A nondiagnostic low-dose unenhanced CT protocol developed by the vendor was used only for attenuation correction and anatomic localization of the PET data. The CT data were acquired with a tube voltage of 120 kVp and reconstructed slice thickness of 3.75 mm; automated tube current modulation was used with the tube current varied from 10 to 210 mA.
CT dose increases linearly with scanning time, which is determined by the rotation time and beam coverage (collimation). A lower pitch will generally increase the dose when all other scanning parameters are kept the same, but only certain combinations of detector-array configurations and pitches are allowed on this scanner model. Thus, to increase beam width from 10 to 20 mm, we used a lower pitch. The goal of x-ray tube current modulation is to make all images contain similar quantum noise independent of patient size and anatomy. To achieve that, we adjusted the tube current to maintain a user-selected noise level in the image data, which is determined by noise index on GE scanners. The maximum tube current value may occur in only an extreme case of a very large patient. The peak kilovoltage value is typically adapted to a specific diagnostic task and average patient diameter. For MDCT, the reconstructed slice thickness is determined by detector configuration and has no primary influence on dose. Indirectly, there may be an effect when the tube current-exposure time product (mAs) value increases to compensate for higher noise when thinner slices are selected. However, a higher slice thickness degrades spatial resolution. Based on this, the tube voltage value, tube current range, and reconstructed slice thickness were not changed during optimization. To avoid a sudden degradation in image quality, we modified the scanning parameters in three steps: First, the x-ray tube rotation time was decreased from 0.8 to 0.5 second; second, the x-ray beam collimation was changed from 16 × 0.625 mm to 16 × 1.25 mm and pitch was changed from 1.75 to 1.35; and, third, the noise index was gradually increased in small increments from 25 to 27.1. The details of the protocol modification are summarized in Table 1 .
To assess radiation dose from the CT component of the examination, we used dose-length product (DLP) values from the scanner-generated dose reports and a conversion factor-that is, the region-specific normalized effective dose per DLP (mSv × mGy −1 × cm −1 ) [18] . Effective dose (ED) was estimated as the product of the DLP and the corresponding conversion factor (k):
For the whole-body scan, we used a k value of 0.015 mSv × mGy −1 × cm −1 , which is the conversion factor suggested for trunk [19] . An initial survey of 140 consecutive patients was conducted before the protocol changes and the mean effective dose was calculated. The patients were not categorized by age, sex, or weight because the same scanning protocol was used with automated tube current modulation, which accounted for differences in patient size. For estimation of the achieved dose savings, we surveyed another 100 consecutive patients scanned after protocol optimization and calculated the mean effective dose using the same method.
To evaluate the impact on image quality, we identified patients who underwent follow-up examinations before and after the optimization. Paired studies of 26 patients who maintained the same weight and were scanned in the same position (arms up) were selected. The studies were blinded and randomized for assessment by an experienced PET and CT reader who is certified by the Royal College of Radiologists in nuclear medicine and diagnostic radiology.
The reader compared studies for 11 anatomic structures and four comprehensive categories including overall quality, noise, contrast resolution, and edge definition. The images were graded using a 4-point scale on the basis of diagnostic acceptability as follows: score of 1, nondiagnostic study; 2, suboptimal study; 3, good study; and 4, excellent study. Mean values and SDs were determined in The results of the image quality assessment are summarized in Table 3 , which shows the means, SDs, and p values for all scoring categories and CTDI vol values. The total group average was 55.81 of 60 for the initial examinations, and it was 54.31 in the follow-up group; however, nine of 26 patients had a higher total score after the optimization. The difference between the means was not statistically significant, with a p value > 0.05 (p = 0.118). The difference in CTDI vol values was significant (p < 0.05), with a 44.1% dose reduction after the optimization. Only two of 15 graded anatomic structures were found to have statistically significant differences between the initial and the follow-up scans. Those structures were the carotid arteries (mean score before vs after optimization, 3.46 vs 3.00, respectively; p = 0.020) and the posterior triangle region (3.81 vs 3.54; p = 0.016), but the scans obtained after optimization still maintained diagnostic accuracy for the purpose. The mean scores in most categories were up to 13.3% higher before the optimization; however, the mean scores of two categories-contrast resolution (3.85) and bowel (3.69)-were unchanged. Three anatomic structures had higher mean scores after the optimization: lung parenchyma (mean score before vs after optimization, 3.86 vs 3.92, respectively), airways (3.62 vs 3.73), and bone (3.65 vs 3.77).
Examples of two patient studies are shown in Figures 1 and 2 , which show images obtained at the same locations in the upper thorax, lungs, and abdomen obtained before (Figs. 1A-1C and 2A-2C) and after (Figs. 1D-1F and 2D-2F) the optimization. Figure  1 shows a 69-year-old woman patient with a body mass index (BMI) of 24. After the protocol change, the CT study scored 52 points, which was 8.8% lower than the score of the initial scan (57 points). However, there was a substantial dose reduction of 47%: The CTDI vol was decreased from 4.89 to 2.59 mGy. Figure  2 shows images of a 65-year-old woman with a BMI of 29. In this study, the score was de- each category. A paired two-tailed Student t test was used to determine the significance of differences between the means of the two distributions (i.e., before vs after optimization). A value of p < 0.05 was considered significant.
Results
Optimization of the whole-body CT component used for attenuation correction and anatomic localization of the PET data resulted in a 32% reduction of the mean CT radiation Tonkopi et al.
creased by 6.7% from 60 to 56 points and the CTDI vol was decreased by 42% (CTDI vol before vs after optimization, 8.26 vs 4.79 mGy).
Discussion
We propose a practical approach for radiation dose reduction in the CT component of PET/CT examinations based on shorter scanning time and lower tube current. This dose reduction was achieved with a faster xray tube rotation time, increased x-ray beam coverage, and higher noise index value. With the chosen beam collimation, the pitch value had to be decreased because only certain combinations of detector configurations and pitches are allowed on the scanner model we use. However, the overall effect of optimization resulted in decreased radiation dose. Implementation of this new protocol is justified by the results of our image quality evaluation. Comparisons of the same patients' studies performed before and after the optimization revealed statistically insignificant differences in the total score, with only a 2.7% decrease in the mean value. Although the overall average score for the reduceddose scans was lower, the images of nine of 26 patients had a higher total score after the optimization. Three anatomic structures had a higher score after the optimization, taking advantage of the lower pitch of 1.35. None of the studies performed after the optimization was graded nondiagnostic in any category.
Our CT protocols were designed for the Healthcare Discovery STE system only, which is one of the limitations of this study. Implementation of the same CT techniques on other systems may result in a higher radiation dose. Different vendors suggest different dose reduction methods; therefore every institution needs to develop scanner-specific protocols for implementing those methods.
Another limitation of our study is the a simplified approach that we used to estimate CT effective dose. In recent years, CT dosimetry has become a highly debated topic [20, 21] . The CTDI vol displayed on the scanner console represents a standardized measure of the radiation output of the CT system, which is measured in a cylindric acrylic phantom of 16 cm in diameter for head examinations or 32 cm in diameter for body examinations. The DLP is the product of CTDI vol and scan length. The published conversion factors refer to a normal-sized patient model, which does not consider variations in body size and shape or differences in age and sex. Therefore, it is not recommended to estimate effective dose for an individual patient using the scanner dose metrics [22] . Some authors have determined sex-and age-specific conversion factors [23] ; others suggest direct physical measurements of absorbed dose using an anthropomorphic phantom with multiple thermoluminescent or MOSFET (metal oxide semiconductor field effect transistor) detectors [24] or sophisticated Monte Carlo simulations based on voxelized patient models [25] . However, in spite of all the controversy, the CTDI vol and DLP are the only dose parameters that can be universally interpreted and compared with national and interna- Note-The images were graded using a 4-point scale on the basis of diagnostic acceptability as follows: score of 1, nondiagnostic study; 2, suboptimal study; 3, good study; and 4, excellent study. a Difference was statistically significant (p < 0.05).
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al patients; our goal was to evaluate dose reduction resulting from the protocol change. For this purpose we compared mean doses from two patient samples surveyed before and after the optimization. When x-ray tube current modulation is used, the CTDI vol and DLP values reflect differences in patient size. The mean values obtained from the patient surveys represent an average patient; therefore, conversion factors may be used for effective dose estimation.
The main contribution to patient dose from a PET/CT examination is from the PET component. The average examination dose was reduced from 16.2 to 13.6 mSv, where 8.1 mSv results from 18 F-FDG. The 32% reduction achieved in CT dose contributed to only a 16% reduction in total dose. However, we need to consider the fact that many patients undergo multiple follow-up examinations, increasing their cumulative radiation dose. Most organizations have adopted the linear no-threshold model [28] for radiation-induced cancer risk estimation; therefore each radiation exposure contributes to lifetime attributable risk. Huang et al. [10] have shown that for a 20-year-old woman, the lifetime attributable risk of cancer incidence is 0.016% per mSv. Therefore, the lifetime attributable risk of cancer incidence associated with radiation dose from one PET/ CT study in our institution was 0.259% before CT dose reduction and 0.217% after the optimization. In our patient population, a 20-yearold woman with non-Hodgkin's lymphoma underwent nine whole-body PET/CT examinations over 3 years; the first PET/CT study was performed when she was 17 years old. Considering that this patient received an average radiation dose from the examination, her lifetime attributable risk of cancer incidence associated with PET/CT would be 1.958%, which was reduced by 0.374% due to CT protocol optimization.
Conclusion
We developed a low-dose CT protocol for attenuation correction and anatomic localization of PET data in whole-body PET/CT examinations and found that optimization of CT acquisition can effectively reduce PET/CT radiation dose without sacrificing image quality. An out-of-box configuration may not be optimized for patient dose and needs to be considered in implementation and clinical procedures. tional reference values for various clinical applications [26] . Effective dose to an average-size patient, which may be estimated using a DLP value, allows comparison with other diagnostic procedures and with natural sources of radiation [27] . This approach is justified for the purpose of our study. We did not intend to estimate doses for individu-
